Mark Poag

Creating the lowest power RF front-end chipsets for the next generation of phased array antennas.

Trener Robotics is a Physical AI company building the intelligence layer for industrial robots. Headquartered in San Jose, California and Trondheim, Norway, we transform robots from rigid, scripted machines into intelligent, self-learning systems that operate reliably in real production environments. Our approach replaces traditional point-to-point programming with training rather than hard-coding, enabling greater flexibility and autonomy. At the core of our platform is Acteris, a standard robot operating brain and integration suite that powers a growing library of production-ready skills. Built on foundation models that combine vision, language, and action understanding, Acteris enables intuitive, scalable automation while keeping deployments repeatable through trusted partners. To advance embodied intelligence, we operate T-Labs, our dedicated R&D engine for robotic skill development and validation. Together, Acteris and T-Labs enable software-defined automation that delivers unprecedented adaptability on the factory floor.

PATH EX, Inc. is a privately held medical device company pioneering a breakthrough approach to sepsis treatment with its innovative CycloPE® device. CycloPE® is designed to directly capture and remove bacteria from the bloodstream, offering a rapid, targeted solution to combat life-threatening infections. The device has demonstrated promising outcomes in preclinical and clinical feasibility studies. PATH EX is advancing toward commercialization, aiming to revolutionize sepsis care and improve patient survival.

Multisensory research and design for the world of Robotics and Human/AI interfaces.

March Biosciences, Inc is a clinical-stage cell therapy company with a mission to transform patient care in the most challenging hematological malignancies. March Bios lead asset is at the end of Phase I trials for T-cell malignancies, diseases with a dismal prognosis that is currently unaddressed by CAR-T and targeted therapy technologies. The companys pipeline is designed to expand on these early successes to more broadly impact other high-challenge cancers.

All kids have extraordinary talent & creativity, and our mission in the world is to help nurture it. We truly believe that education needs to develop the whole being, and exploration of broad interests is key for originality.

DetraPel is the advanced materials parent parent company of our industrial vertical - Impermea Materials, consumer brand - ProofPlus™, & contract manufacturing division - DetraPel Solutions. DetraPel develops cancer-free, plastic-free, PFAS-free (100% fluorine-free) coatings that provide superior performance and actually work while staying sustainable. DetraPel creates solutions for paper & food packaging, textiles, healthcare, consumer packaged goods, and more. Our technologies enhance durability, resistance, and performance of various substrates while maintaining recyclability, composability, and repulpability. Leading innovation in surface protection. Committed to sustainability. Join us in shaping a resilient, eco-friendly future.

Realworld is the mobile app on a mission to simplify adulthood for the next generation. Step-by-step playbooks educate members about personal finance, health care, renting and more, by providing actionable information and product recommendations for life in the real world.

Celestial AI was acquired by Marvell Technology in February 2026. This page is no longer active. Please follow Marvell Technology (https://www.linkedin.com/company/marvell/) for updates.

Verge Genomics is a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data. Verge is focused on developing therapeutics for complex diseases with high unmet need, using human genomics from patient disease tissues and machine learning. Verge has created a proprietary all-in-human CONVERGE® platform, featuring one of the field’s largest and most comprehensive databases of multi-omic patient data. The company is led by experienced computational biologists and drug developers who are successfully advancing clinical and preclinical therapeutic programs in various diseases, including ALS and Parkinson’s disease. Verge actively seeks a diverse applicant pool in order to build the strongest possible workforce. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

At Poplar, we make impact accessible. We build solutions to collect food waste and connect people to the broader network of pros, haulers and processors who properly recycle it. Plus, members stay informed of their contribution from the moment it leaves their home to the positive impact it has along the way.

Individuals, businesses, and industries can work better with blockchain technology. BlockApps is the leader in Web3Commerce. We unlock the value of real-world assets by making them more trusted, transparent, and fair.

At Spruce, we are on a mission to change how people receive services in their homes. From full housekeeping to a quick tidy up or a bathroom deep clean, Spruce is available to residents on-demand. With over 30 different services, including 15 priced between $10 and $30, residents get access to a la carte services that have never before been available to consumers. For the property manager, Spruce reduces the growing burden of managing 20+ different providers arriving each day, and provides security and oversight for the entire property. Spruce also helps local housekeeping and cleaning businesses build economies of scale in their operations with tech-enabled solutions so that they can compete in the modern economy. These local partnerships help Spruce provide a higher quality service than is achievable through independent contractors, and Spruce passes scale benefits through to residents in the form of lower prices.

NomadGo, an innovator in inventory management, has combined computer vision technology and augmented reality to digitize any space. Whether streamlining inventory counts or transforming the supply chain with automated ordering, Nomad Go’s innovative platform powers business decisions.

Cartful Solutions improves eCommerce sales conversion and shopper satisfaction by delivering a more persuasive product recommendation experience.

Creating the lowest power RF front-end chipsets for the next generation of phased array antennas.

Trener Robotics is a Physical AI company building the intelligence layer for industrial robots. Headquartered in San Jose, California and Trondheim, Norway, we transform robots from rigid, scripted machines into intelligent, self-learning systems that operate reliably in real production environments. Our approach replaces traditional point-to-point programming with training rather than hard-coding, enabling greater flexibility and autonomy. At the core of our platform is Acteris, a standard robot operating brain and integration suite that powers a growing library of production-ready skills. Built on foundation models that combine vision, language, and action understanding, Acteris enables intuitive, scalable automation while keeping deployments repeatable through trusted partners. To advance embodied intelligence, we operate T-Labs, our dedicated R&D engine for robotic skill development and validation. Together, Acteris and T-Labs enable software-defined automation that delivers unprecedented adaptability on the factory floor.

PATH EX, Inc. is a privately held medical device company pioneering a breakthrough approach to sepsis treatment with its innovative CycloPE® device. CycloPE® is designed to directly capture and remove bacteria from the bloodstream, offering a rapid, targeted solution to combat life-threatening infections. The device has demonstrated promising outcomes in preclinical and clinical feasibility studies. PATH EX is advancing toward commercialization, aiming to revolutionize sepsis care and improve patient survival.

Multisensory research and design for the world of Robotics and Human/AI interfaces.

March Biosciences, Inc is a clinical-stage cell therapy company with a mission to transform patient care in the most challenging hematological malignancies. March Bios lead asset is at the end of Phase I trials for T-cell malignancies, diseases with a dismal prognosis that is currently unaddressed by CAR-T and targeted therapy technologies. The companys pipeline is designed to expand on these early successes to more broadly impact other high-challenge cancers.